InspireMD, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NSPR research report →
Range $3 – $5
Price Chart
About the company
InspireMD, Inc. , an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases.
- CEO
- Marvin L. Slosman
- IPO
- 2011
- Employees
- 127
- HQ
- Miami, FL, US
Get TickerSpark's AI analysis on NSPR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $42.15M
- P/E
- -1.81
- PEG
- -0.04
- P/S
- 3.89
- P/B
- 2.10
- EV/EBITDA
- -0.76
- Div Yield
- 0.00%
- Gross Margin
- 18.05%
- Op Margin
- -494.03%
- Net Margin
- -355.17%
- ROE
- -79.21%
- ROIC
- -153.04%
Latest fiscal year · YoY change
- Revenue
- $8.98M+28.1%
- Gross Profit
- $2.65M+75.9%
- Op Income
- $-49,112,000
- Net Income
- $-48,786,000-52.4%
- EPS
- $-0.76+0.0%
- OCF Growth
- -60.5%
- FCF Growth
- -58.0%
- 52W High
- $2.57
- 52W Low
- $0.63
- 50D MA
- $0.73
- 200D MA
- $1.39
- Beta
- 0.77
- RSI (14)
- 63
- Avg Volume
- 116.44K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the NSPR Q2 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 56.1%
- Shares Outstanding
- 46.84M
- Float Shares
- 26.29M
of shares held by institutions
44 13F filers
Buy/sell ratio 11.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Retirement Group, LLC | 4 | 0 |
Held by 2 ETFs
Biggest fund positions in NSPR by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 27, 26 | Stuka Paul | buy | 20,000 |
| Jan 27, 25 | Gleason Shane Thomas | sell | 3,858 |
| Jan 28, 25 | Gleason Shane Thomas | sell | 2,476 |
| Jan 29, 25 | Gleason Shane Thomas | sell | 3,660 |
| Jan 30, 25 | Gleason Shane Thomas | sell | 2,454 |
| Jan 31, 25 | Gleason Shane Thomas | sell | 9,923 |
| Feb 3, 25 | Gleason Shane Thomas | sell | 7,073 |
| Feb 4, 25 | Gleason Shane Thomas | sell | 5,132 |
| Feb 25, 25 | Gleason Shane Thomas | sell | 10,000 |
| May 23, 25 | Gleason Shane Thomas | sell | 2,482 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NSPR coverage
Recent articles, reports, and earnings notes.
No research on NSPR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NSPR report →InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know
zacks.com · Aug 20
InspireMD, Inc. (NSPR) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 17
InspireMD Reports Second Quarter 2026 Financial Results
globenewswire.com · Aug 17
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates
zacks.com · Aug 14
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com · Aug 7
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing
globenewswire.com · Jul 30
InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR
zacks.com · Jun 16
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com · Jun 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.